Home > Chemicals & Materials > Surfactants > Biodegradable Surfactants > Biosurfactants Market
Biosurfactants Market Analysis
- Report ID: GMI484
- Published Date: Apr 2023
- Report Format: PDF
Biosurfactants Market Analysis
The rhamnolipids biosurfactants market is poised to be worth over USD 3 billion by 2032. Rhamnolipids are extensively utilized across the pharmaceutical and therapeutics industries owing to their low toxicity and capability to inhibit the growth of several human cancer cell lines. Moreover, the expanding product applications in personal care products due to its increased solubility and good foaming & wetting tendencies have led to of the use of rhamnolipids in cosmetic industry.
Rhamnolipids are used in healthcare products in different formulations including antacids, acne pads, anti-dandruff products, and contact lens solution. Rhamnolipids are effective in wound healing, treatments, preventing gum diseases, and averting antimicrobial & antiviral activities. These factors are anticipated to drive the rhamnolipids demand in pharmaceutical applications and subsequently stimulate market expansion.
The sophorolipids biosurfactants market from personal care application segment was worth over USD 720 million in 2022 and is expected to witness around 7.5% CAGR through 2032. Sophorolipids are widely used as foaming agents, emulsifiers, wetting agents, solubilizers, and active ingredients in several cosmetic formulations. The tremendous uptick in demand for personal care and cosmetic products driven by the increasing expenditure on beauty and aesthetics will bring about lucrative gains to the bio based surfactants industry.
North America biosurfactants market from mannosylerythritol products is projected to amass more than USD 1 billion by 2032. Mannosylerythritol Lipids (MEL) have antimicrobial properties, hence are used for manufacturing face masks, face wash, and other skin care products. The regional growth can be credited to the rising disposable incomes and the increasing sales of cosmetics and personal care products. Besides, the growing awareness about mental health coupled with the proven effectiveness of mannosylerythritol lipids in treating schizophrenia and other diseases caused by microbial infections and dopamine metabolic dysfunction will fuel the regional industry landscape. Asia Pacific Biosurfactants industry is estimated to grow at over 5.5% CAGR in the coming years owing to widening applications and ecofriendly aspects.
Frequently Asked Questions (FAQ) :
Biosurfactants Market Scope
